Indeterminate liver lesions on gadoxetic acid-enhanced magnetic resonance imaging of the liver: Case-based radiologic-pathologic review

被引:2
作者
Noreikaite, Jurate [1 ]
Albasha, Dekan [1 ]
Chidambaram, Vijay [1 ]
Arora, Ankur [1 ]
Katti, Ashok [1 ]
机构
[1] Liverpool Univ Hosp NHS Fdn Trust, Dept Radiol, Prescot St, Liverpool L7 8XP, Merseyside, England
关键词
Indeterminate liver lesions; Magnetic resonance imaging; Gadoxetic acid; Hepatobiliary phase; Hepatocellular carcinoma; FOCAL NODULAR HYPERPLASIA; HEPATOCELLULAR-CARCINOMA; HEPATOBILIARY-PHASE; NEUROENDOCRINE TUMORS; RISK-FACTORS; INTRAHEPATIC CHOLANGIOCARCINOMA; HEPATIC ANGIOMYOLIPOMA; MRI; ADENOMA; DIFFERENTIATION;
D O I
10.4254/wjh.v13.i9.1079
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Different histopathological manifestations of focal liver lesions show varying common and uncommon imaging findings and some pathologies may show similar appearance despite of different histopathology. It is necessary to characterise focal liver lesions accurately as not only benign and malignant lesions are managed differently, but also certain benign lesions have differing management. These lesions are increasingly being detected due to rapid growth of use of cross-sectional imaging as well as improvement in image quality and new imaging techniques. Contrast enhanced magnetic resonance imaging (MRI) is considered the gold standard technique in characterising focal liver lesions. Addition of gadoxetic acid has been shown to significantly increase diagnostic accuracy in the detection and characterization of liver abnormalities. Classic imaging characteristics of common liver lesions, including their behaviour on gadoxetic acid enhanced MRI, have been described in literature over recent years. It is important to be familiar with the typical aspects of these lesions as well as know the uncommon and overlapping imaging features to reach an accurate diagnosis. In this article, we will review the well-described characteristic imaging findings of common and rare focal liver lesions and present several challenging cases encountered in the clinical setting, namely hepatocellular adenoma, focal nodular hyperplasia, hepatic angiomyolipoma, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, neuroendocrine tumours as well as a pleomorphic liposarcoma of the liver.</p>
引用
收藏
页码:1079 / 1097
页数:20
相关论文
共 50 条
[31]   The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma [J].
Kim, Jung Hee ;
Min, Yang Won ;
Gwak, Geum-Youn ;
Paik, Yong Han ;
Choi, Moon Seok ;
Lee, Joon Hyoek ;
Koh, Kwang Cheol ;
Paik, Seung Woon .
MEDICINE, 2016, 95 (51) :e5666
[32]   Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma [J].
Yi-Chen Chou ;
I-Ha Lao ;
Pei-Ling Hsieh ;
Ying-Ying Su ;
Chee-Wai Mak ;
Ding-Ping Sun ;
Ming-Jen Sheu ;
Hsing-Tao Kuo ;
Tzu-Ju Chen ;
Chung-Han Ho ;
Yu-Ting Kuo .
World Journal of Gastroenterology, 2019, 25 (21) :2636-2649
[33]   Half-dose gadoxetic acid-enhanced liver magnetic resonance imaging in patients at risk for nephrogenic systemic fibrosis [J].
Song, Kyoung Doo ;
Kim, Seong Hyun ;
Lee, Jisun ;
Kang, Kyung A. ;
Kim, Joungyoun ;
Yoo, Heejin .
EUROPEAN JOURNAL OF RADIOLOGY, 2015, 84 (03) :378-383
[34]   Double-Dose Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients With Chronic Liver Disease [J].
Motosugi, Utaroh ;
Ichikawa, Tomoaki ;
Sano, Katsuhiro ;
Sou, Hironobu ;
Onohara, Kojiro ;
Muhi, Ali ;
Kitamura, Takatoshi ;
Amemiya, Fumitake ;
Enomoto, Nobuyuki ;
Matsuda, Masanori ;
Asakawa, Masami ;
Fujii, Hideki ;
Araki, Tsutomu .
INVESTIGATIVE RADIOLOGY, 2011, 46 (02) :141-145
[35]   Prediction of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma using imaging features of gadoxetic acid-enhanced magnetic resonance imaging [J].
Byun, Jieun ;
Kim, So Yeon ;
Kim, Jin Hyoung ;
Kim, Min Ju ;
Yoo, Changhoon ;
Shim, Ju Hyun ;
Lee, Seung Soo .
ACTA RADIOLOGICA, 2021, 62 (12) :1548-1558
[36]   Characteristics of false-positive lesions in evaluating colorectal liver metastases on gadoxetic acid-enhanced magnetic resonance imaging [J].
Yamada, Shuhei ;
Kishi, Yoji ;
Miyake, Mototaka ;
Nara, Satoshi ;
Esaki, Minoru ;
Shimada, Kazuaki .
SURGERY TODAY, 2022, 52 (08) :1178-1184
[37]   Liver Imaging Reporting and Data System on CT and gadoxetic acid-enhanced MRI with diffusion-weighted imaging [J].
Cha, Dong Ik ;
Jang, Kyung Mi ;
Kim, Seong Hyun ;
Kang, Tae Wook ;
Song, Kyoung Doo .
EUROPEAN RADIOLOGY, 2017, 27 (10) :4394-4405
[38]   Is Liver-Specific Gadoxetic Acid-Enhanced Magnetic Resonance Imaging a Reliable Tool for Detection of Hepatocellular Carcinoma in Patients with Chronic Liver Disease? [J].
Wu, Lian-Ming ;
Xu, Jian-Rong ;
Gu, Hai-Yan ;
Hua, Jia ;
Chen, Jie ;
Zhu, Jiong ;
Zhang, Wei ;
Hu, Jiani .
DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (11) :3313-3325
[39]   Preoperative Prediction of Cytokeratin 19 Expression for Hepatocellular Carcinoma with Deep Learning Radiomics Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging [J].
Chen, Yuying ;
Chen, Jia ;
Zhang, Yu ;
Lin, Zhi ;
Wang, Meng ;
Huang, Lifei ;
Huang, Mengqi ;
Tang, Mimi ;
Zhou, Xiaoqi ;
Peng, Zhenpeng ;
Huang, Bingsheng ;
Feng, Shi-Ting .
JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 :795-808
[40]   Hepatocellular carcinoma with central scar on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance imaging [J].
Han, Sol Bee ;
Kim, Young Kon ;
Min, Ji Hye ;
Ha, Sang Yun ;
Jeong, Woo Kyung ;
Lee, Won Jae .
ACTA RADIOLOGICA, 2018, 59 (04) :393-401